DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.13
+0.01 (0.14%)
Jun 17, 2026, 4:00 PM EDT - Market closed
DarioHealth Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 14.98 | 21.8 | 27.76 | 36.8 | 49.36 | 35.81 |
Short-Term Investments | 5.04 | 4.21 | 0.7 | - | - | - |
Cash & Short-Term Investments | 20.01 | 26.02 | 28.46 | 36.8 | 49.36 | 35.81 |
Cash Growth | -28.15% | -8.59% | -22.65% | -25.45% | 37.84% | 25.25% |
Accounts Receivable | 2.22 | 2.14 | 4.8 | 3.16 | 6.42 | 1.31 |
Inventory | 4.17 | 4.32 | 4.75 | 5.06 | 7.96 | 6.23 |
Other Current Assets | 2.33 | 2.59 | 2.51 | 2.32 | 1.8 | 2.26 |
Total Current Assets | 28.73 | 35.07 | 40.53 | 47.33 | 65.52 | 45.61 |
Net Property, Plant & Equipment | 1.12 | 1.27 | 1.77 | 1.87 | 1.99 | 0.99 |
Other Intangible Assets | 15.47 | 15.93 | 18.76 | 5.4 | 9.92 | 12.46 |
Goodwill | 57.43 | 57.43 | 57.43 | 41.64 | 41.64 | 41.64 |
Other Long-Term Assets | 0.53 | 0.38 | 0.39 | 0.15 | 0.12 | 0.08 |
Total Assets | 103.28 | 110.08 | 118.88 | 96.39 | 119.19 | 100.77 |
Accounts Payable | 3.47 | 2.93 | 3.05 | 1.13 | 2.32 | 5.11 |
Accrued Expenses | 5.01 | 5.25 | 6.05 | 6.3 | 6.59 | 7.81 |
Current Portion of Long-Term Debt | - | - | 5.45 | 3.95 | 8.82 | - |
Current Portion of Leases | 0.38 | 0.43 | 0.5 | 0.11 | 0.29 | 0.27 |
Unearned Revenue | 0.5 | 0.71 | 1.58 | 1 | 1.32 | 1.2 |
Total Current Liabilities | 9.36 | 9.32 | 16.64 | 12.49 | 19.35 | 14.38 |
Long-Term Debt | 30.93 | 30.75 | 23.47 | 24.59 | 18.11 | - |
Long-Term Leases | 0.51 | 0.57 | 0.77 | 0.89 | 0.83 | 0.02 |
Other Long-Term Liabilities | 0.11 | 1.51 | 5.99 | 0.28 | 0.91 | 0.83 |
Total Long-Term Liabilities | 31.54 | 32.83 | 30.23 | 25.75 | 19.84 | 0.85 |
Total Liabilities | 40.9 | 42.15 | 46.87 | 38.25 | 39.19 | 15.22 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | 522.7 | 520 | 462.36 | 407.5 | 365.85 | 307.56 |
Retained Earnings | -460.33 | -452.08 | -390.34 | -349.36 | -285.85 | -222.01 |
Shareholders' Equity | 62.38 | 67.92 | 72.02 | 58.14 | 80 | 85.55 |
Total Liabilities & Equity | 103.28 | 110.08 | 118.88 | 96.39 | 119.19 | 100.77 |
Total Debt | 31.82 | 31.75 | 30.19 | 29.54 | 28.05 | 0.29 |
Net Cash (Debt) | -11.8 | -5.73 | -1.73 | 7.26 | 21.31 | 35.52 |
Net Cash Growth | - | - | - | -65.95% | -40.01% | 26.60% |
Net Cash Per Share | -2.35 | -1.44 | -0.71 | 5.12 | 18.03 | 42.82 |
Book Value | 62.38 | 67.92 | 72.02 | 58.14 | 80 | 85.55 |
Book Value Per Share | 12.41 | 17.05 | 29.37 | 40.99 | 67.70 | 103.12 |
Tangible Book Value | -10.52 | -5.44 | -4.17 | 11.1 | 28.44 | 31.45 |
Tangible Book Value Per Share | -2.09 | -1.36 | -1.70 | 7.82 | 24.07 | 37.91 |